| scholarly article | Q13442814 |
| P2093 | author name string | L Q Vieira | |
| C D Rocha | |||
| J Lannes-Vieira | |||
| N M Silva | |||
| R T Gazzinelli | |||
| V Michailowsky | |||
| P2860 | cites work | Trypanosoma cruzi meningoencephalitis in HIV-infected patients | Q33546054 |
| Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice | Q33597343 | ||
| Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease | Q34000030 | ||
| Effects of interleukin-4 deprivation and treatment on resistance to Trypanosoma cruzi | Q34003863 | ||
| Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro | Q34546031 | ||
| Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages | Q35457307 | ||
| Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells | Q35462159 | ||
| Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes | Q35494931 | ||
| Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism | Q35746981 | ||
| Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease | Q35779913 | ||
| Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs | Q35810210 | ||
| Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets | Q36355870 | ||
| T cell genetic background determines default T helper phenotype development in vitro | Q36364428 | ||
| Genetics of murine resistance to Trypanosoma cruzi. | Q36435831 | ||
| Genetic control of responses to Trypanosoma cruzi in mice: multiple genes influencing parasitemia and survival | Q36441021 | ||
| Chagas' disease: CD5 B-cell-dependent Th2 pathology? | Q36671183 | ||
| The indeterminate form of human chronic Chagas' disease A clinical epidemiological review | Q38215235 | ||
| Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: Light microscopy and immunohistochemical findings | Q39067405 | ||
| Trypanosoma cruzi induces strong IL-12 and IL-18 gene expression in vivo: correlation with interferon-gamma (IFN-gamma) production | Q39248577 | ||
| Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection | Q39419338 | ||
| Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi | Q39559044 | ||
| Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase | Q39570411 | ||
| Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans | Q39573339 | ||
| Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study | Q40649314 | ||
| Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. | Q40735125 | ||
| Impaired interleukin 12 production in human immunodeficiency virus-infected patients | Q41478389 | ||
| The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta | Q41600919 | ||
| Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. | Q41617474 | ||
| Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi | Q41823109 | ||
| Influence of Trypanosoma cruzi strain on the pathogenesis of chronic myocardiopathy in mice | Q43772956 | ||
| Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi | Q44684713 | ||
| Reactivation of Chagas' disease in a human immunodeficiency virus-infected patient leading to severe heart disease with a late positive direct microscopic examination of the blood. | Q45752490 | ||
| Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection. | Q52522603 | ||
| CHRONIC AND PROGRESSIVE MYOCARDITIS AND MYOSITIS IN C3H MICE INFECTED WITH TRYPANOSOMA CRUZI. | Q52630738 | ||
| Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. | Q54296214 | ||
| Chagas' disease: Trypanosoma cruzi vs. the host immune system | Q57842381 | ||
| Chagas' disease encephalitis: intense CD8+ lymphocytic infiltrate is restricted to the acute phase, but is not related to the presence of Trypanosoma cruzi antigens | Q58842381 | ||
| Differential tissue distribution of diverse clones of Trypanosoma cruzi in infected mice | Q58842411 | ||
| Myocardial parasite persistence in chronic chagasic patients | Q58842412 | ||
| An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens | Q58843149 | ||
| IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi | Q58843169 | ||
| PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease | Q58843303 | ||
| Chagasic meningoencephalitis with detection of Trypanosoma cruzi in the cerebrospinal fluid of an immunodepressed patient | Q58843842 | ||
| Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy | Q58844325 | ||
| Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi | Q58845221 | ||
| Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi | Q58846768 | ||
| Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome | Q70468096 | ||
| The mechanisms of Trypanosoma cruzi invasion of mammalian cells | Q70899913 | ||
| HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines | Q71961117 | ||
| Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii | Q73948679 | ||
| Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship | Q77579665 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nervous system | Q9404 |
| Trypanosoma cruzi | Q150162 | ||
| P304 | page(s) | 1723-1733 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection | |
| P478 | volume | 159 |
| Q54216786 | A novel strategy to adapt SHIV-E1 carrying env from an RV144 volunteer to rhesus macaques: coreceptor switch and final recovery of a pathogenic virus with exclusive R5 tropism. |
| Q33760119 | A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease |
| Q41951713 | Activity of cholinesterases and adenosine deaminase in blood and serum of rats experimentally infected with Trypanosoma cruzi |
| Q37215305 | Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infection |
| Q37721788 | Alternatively Activated Macrophages Revisited: New Insights into the Regulation of Immunity, Inflammation and Metabolic Function following Parasite Infection |
| Q42497203 | Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity? |
| Q37474041 | Arginase in parasitic infections: macrophage activation, immunosuppression, and intracellular signals |
| Q38009776 | Autonomic neuroimmunomodulation in chagasic cardiomyopathy |
| Q47093622 | Benznidazole affects expression of Th1, Th17 and Treg cytokines during acute experimental Trypanosoma cruzi infection. |
| Q27346448 | CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathy |
| Q34125557 | Chagas disease cardiomyopathy: immunopathology and genetics |
| Q24791610 | Chagas' disease and AIDS |
| Q47361351 | Chagas' disease susceptibility/resistance: linkage disequilibrium analysis suggests epistasis between major histocompatibility complex and interleukin-10. |
| Q37310959 | Chagas' disease: an update on immune mechanisms and therapeutic strategies |
| Q42922252 | Characteristic pattern of skeletal muscle remodelling in different mouse strains |
| Q40051563 | Crucial role for T cell-intrinsic IL-18R-MyD88 signaling in cognate immune response to intracellular parasite infection |
| Q36788489 | Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium |
| Q58843342 | Different parasite inocula determine the modulation of the immune response and outcome of experimental Trypanosoma cruzi infection |
| Q39863865 | Differential interleukin-8 and nitric oxide production in epithelial cells induced by mucosally invasive and noninvasive Trypanosoma cruzi trypomastigotes |
| Q60047543 | Disease Tolerance and Pathogen Resistance Genes May Underlie Persistence and Differential Progression to Chagas Disease Cardiomyopathy |
| Q38927945 | Epstein-Barr virus-induced gene 3 suppresses T helper type 1, type 17 and type 2 immune responses after Trypanosoma cruzi infection and inhibits parasite replication by interfering with alternative macrophage activation |
| Q58845922 | Essential role of VLA-4/VCAM-1 pathway in the establishment of CD8+ T-cell-mediated Trypanosoma cruzi-elicited meningoencephalitis |
| Q36637937 | Evolution and pathology in chagas disease--a review |
| Q37535347 | Frequency of IFNγ-producing T cells correlates with seroreactivity and activated T cells during canine Trypanosoma cruzi infection |
| Q35884259 | Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection |
| Q33267316 | Genes from Chagas susceptibility loci that are differentially expressed in T. cruzi-resistant mice are candidates accounting for impaired immunity |
| Q40106394 | IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites. |
| Q35659197 | IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection |
| Q27339616 | IL-12p40 deficiency leads to uncontrolled Trypanosoma cruzi dissemination in the spinal cord resulting in neuronal death and motor dysfunction |
| Q30452989 | Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection |
| Q37597069 | Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy |
| Q35692509 | Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV |
| Q34271214 | Inducible nitric oxide synthase in heart tissue and nitric oxide in serum of Trypanosoma cruzi-infected rhesus monkeys: association with heart injury |
| Q34756581 | Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice |
| Q33997924 | Induction of IL-12 production in human peripheral monocytes by Trypanosoma cruzi Is mediated by glycosylphosphatidylinositol-anchored mucin-like glycoproteins and potentiated by IFN- γ and CD40-CD40L interactions |
| Q92380473 | Infection by Trypanosoma cruzi in the central nervous system in non-human mammals: a systematic review |
| Q34043775 | Inflammasomes in host response to protozoan parasites. |
| Q35994773 | Innate and acquired immunity in the pathogenesis of Chagas disease |
| Q39179244 | Interaction of natural killer cells with Trypanosoma cruzi-infected fibroblasts |
| Q35103439 | Interferon-gamma promotes infection of astrocytes by Trypanosoma cruzi |
| Q92190807 | Interleukin (IL)-21 in Inflammation and Immunity During Parasitic Diseases |
| Q39030716 | Interleukin-12 but not interleukin-18 is required for immunity to Trypanosoma cruzi in mice |
| Q36370643 | Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications |
| Q35565161 | MIF synergizes with Trypanosoma cruzi antigens to promote efficient dendritic cell maturation and IL-12 production via p38 MAPK. |
| Q34681102 | Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection. |
| Q34727502 | Macrophage signaling by glycosylphosphatidylinositol-anchored mucin-like glycoproteins derived from Trypanosoma cruzi trypomastigotes. |
| Q58845056 | Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS |
| Q46745641 | Melatonin enhances pro-inflammatory cytokine levels and protects against Chagas disease |
| Q37328752 | MnSODtg mice control myocardial inflammatory and oxidative stress and remodeling responses elicited in chronic Chagas disease |
| Q33282864 | Modulation of CD4(+) T cell-dependent specific cytotoxic CD8(+) T cells differentiation and proliferation by the timing of increase in the pathogen load |
| Q27022885 | Modulation of immune response in experimental Chagas disease |
| Q40206121 | Myenteric neuroprotective role of aspirin in acute and chronic experimental infections with Trypanosoma cruzi |
| Q34053139 | Myocardial gene expression of T-bet, GATA-3, Ror-γt, FoxP3, and hallmark cytokines in chronic Chagas disease cardiomyopathy: an essentially unopposed TH1-type response |
| Q64916705 | Myocarditis in Humans and in Experimental Animal Models. |
| Q34163899 | NADPH phagocyte oxidase knockout mice control Trypanosoma cruzi proliferation, but develop circulatory collapse and succumb to infection. |
| Q39179252 | NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms |
| Q37409820 | NLR proteins and parasitic disease |
| Q35010454 | NLRP3 controls Trypanosoma cruzi infection through a caspase-1-dependent IL-1R-independent NO production |
| Q34298453 | Parasite-derived neurotrophic factor/trans-sialidase of Trypanosoma cruzi links neurotrophic signaling to cardiac innate immune response |
| Q43251669 | Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection |
| Q98177690 | Polymorphisms in Genes Affecting Interferon-γ Production and Th1 T Cell Differentiation Are Associated With Progression to Chagas Disease Cardiomyopathy |
| Q95841203 | Precision Health for Chagas Disease: Integrating Parasite and Host Factors to Predict Outcome of Infection and Response to Therapy |
| Q37145066 | Preferential brain homing following intranasal administration of Trypanosoma cruzi |
| Q36385075 | Probing Trypanosoma cruzi biology with DNA microarrays |
| Q91813186 | Reactive species and pathogen antioxidant networks during phagocytosis |
| Q35147723 | Requirement of UNC93B1 reveals a critical role for TLR7 in host resistance to primary infection with Trypanosoma cruzi |
| Q44360313 | Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response |
| Q40119715 | Role of Inactive and Active Trypanosoma cruzi Trans-sialidases on T Cell Homing and Secretion of Inflammatory Cytokines |
| Q37028880 | Role of TLRs/MyD88 in host resistance and pathogenesis during protozoan infection: lessons from malaria. |
| Q35884180 | Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. |
| Q43550922 | Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection. |
| Q35758872 | The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole |
| Q27314524 | The Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruzi |
| Q58705710 | The Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease |
| Q37788829 | The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease |
| Q43013320 | Toll-like receptor 2 regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi |
| Q35088408 | Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity |
| Q52619024 | Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine. |
| Q37086096 | Trypanosoma cruzi antioxidant enzymes as virulence factors in Chagas disease |
| Q35621200 | Trypanosoma cruzi as an effective cancer antigen delivery vector. |
| Q35361340 | Trypanosoma cruzi evades the protective role of interferon-gamma-signaling in parasite-infected cells |
| Q44936820 | Trypanosoma cruzi infection: a continuous invader-host cell cross talk with participation of extracellular matrix and adhesion and chemoattractant molecules |
| Q38594321 | Trypanosoma cruzi parasites fight for control of the JAK-STAT pathway by disarming their host |
| Q46009587 | Trypanosoma cruzi: dehydroepiandrosterone (DHEA) and immune response during the chronic phase of the experimental Chagas' disease. |
| Q34032964 | Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease. |
| Q42649294 | Two sides to every proinflammatory coin: new insights into the role of dendritic cells in the regulation of T-cell driven autoimmune myocarditis |
| Q34931909 | Type I interferons increase host susceptibility to Trypanosoma cruzi infection |
| Q41963043 | Ultrastructural study on tissue alterations caused by trypanosomatids in experimental murine infections |
| Q60932659 | Upregulation of Cardiac IL-10 and Downregulation of IFN- in Balb/c IL-4 in Acute Chagasic Myocarditis due to Colombian Strain of Trypanosoma cruzi |
| Q34700649 | Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infection |
Search more.